Following the announcement that Starpharma received TGA approval for VivaGel coated condoms in Australia, the AFR reported on the significance of the deal for Australian innovation. It quotes CEO Jackie Fairley quoted as saying “It is particularly satisfying to be seeing this product come to market in Australia, [which will be] among one of the first markets in the world to have access to the product”. Reporter Jessica Gardner also notes that there is a significant global market and interest for the product, as well as the local market, where Ansell currently holds a 70 per cent market share.

 Gardner also reported that Starpharma shares were up 13% at the time of publication.